FDA Approves Rituxan-Chemotherapy Combo for Children with a Variety of Blood Cancers
Dec 10, 2021
1 min read
The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia.
Comments